NEW YORK (CBSNewYork/AP) — The CEO and chairman of Goldman Sachs says that he has a form of lymphoma that is “highly curable.”
Lloyd Blankfein said in a post on the firm’s website Tuesday that he underwent a series of tests after not feeling well for several weeks. The executive said that he’ll receive chemotherapy in New York over the next several months as part of his treatment plan.READ MORE: Stimulus Check Update: When Could Another Economic Relief Payment Arrive?
To my colleagues, our clients and our shareholders,
Late this summer after several weeks of not feeling well, I underwent a series of tests, which culminated in a biopsy last week. After the biopsy, I was told by my doctors that I have lymphoma. Fortunately, my form of lymphoma is highly curable and my doctors’ and my own expectation is that I will be cured.
My treatment plan will include chemotherapy over the next several months in New York. My doctors have advised me that during the treatment, I will be able to work substantially as normal, leading the firm. I will, however, reduce some of my previously planned travel during the treatment period. I have discussed this approach with our Board of Directors and they are supportive.
There are many people who are dealing with cancer every day. I draw on their experiences as I begin my own. I have a lot of energy and I’m anxious to begin the treatment. I appreciate your support and good wishes.
LloydREAD MORE: Wife Of Top Cuomo Aide Shows Support On Social Media For Governor's Latest Sexual Harassment Accuser
Blankfein, who’s also known for his philanthropy, said he’ll reduce travel during treatment but will be able to “work substantially as normal.”
Blankfein said he’s discussed his planned work approach with the Goldman Sachs board and that they are supportive.
Shares of the New York-based company fell slightly in pre-market trading.MORE NEWS: Road To Reopening: Prudential Center Set To Welcome Fans Back For Devils-Islanders Game
(TM and © Copyright 2015 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2015 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)